Thank you for subscribing!
Finfeed Archived Mar 09, 2021
Today, Creso Pharma Limited (ASX:CPH, FRA:1X8) announced a Letter of Interest (LOI) which marks its entry into the CBD market for sport and recreation; an industry whose global valuation is estimated at US$22Bn by 2022 and C$220m in Canada alone.
Get expert stock analysis direct in your inbox
Join Our Mailing List